Glioblastoma-specific anti-TUFM nanobody for in-vitro immunoimaging and cancer stem cell targeting

Glioblastoma multiforme (GBM) is the most common and lethal form of brain tumor. The prognosis for patients remains poor, despite the combination of new preoperative and intraoperative neuroimaging, radical surgery, and recent advances in radiotherapy and chemotherapy. To improve GBM therapy and pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Samec, Neja, Jovcevska, Ivana, Stojan, Jure, Zottel, Alja, Liovic, Mirjana, Myers, Michael P., Muyldermans, Serge, Šribar, Jernej, Križaj, Igor, Komel, Radovan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915116/
https://www.ncbi.nlm.nih.gov/pubmed/29707108
http://dx.doi.org/10.18632/oncotarget.24629

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5915116/
https://www.ncbi.nlm.nih.gov/pubmed/29707108
http://dx.doi.org/10.18632/oncotarget.24629

Ejemplares similares